FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to isoindolones of formula 1: or pharmaceutically acceptable salts thereof, wherein: Z1 means CR1R1a; R1 and R1a independently mean H; Z2 means CR2; R2 means H; Z3 means CR3; R3 means H; R4 means H; Y means W-C(O); W means R5 means H; X1 means -OR11'; R11' independently means H, C1-C12-alkyl which may be substituted by one -(CR19R20)nOR16, wherein R16 means H; R6 and R6' independently mean H, halogen; provided both R6 and R6' mean other than H simultaneously; n and p are is equal to 0, 1, 2 or 3; R19 and R20 independently mean H.
EFFECT: compounds inhibit the abnormal cell growth that enables using them to prepare the pharmaceutical composition effective for treating a hyperproliferative disease in a mammal.
8 cl, 5 dwg, 5 ex
Title | Year | Author | Number |
---|---|---|---|
8-ANILINOIMIDAZOPYRIDINES AND METHODS FOR USE THEREOF | 2008 |
|
RU2498985C2 |
AZABENZOTHIOPHENYL COMPOUNDS AND METHODS OF USE | 2007 |
|
RU2444524C2 |
BICYCLIC HETEROCYCLES AS MEK KINASE INHIBITORS | 2009 |
|
RU2509078C2 |
COMPOSITIONS FOR TREATING CANCER USING ANTAGONISTS WHICH BIND TO THE PD-1 SIGNALING PATHWAY COMPONENT AND MEK INHIBITORS | 2015 |
|
RU2733735C2 |
5-ANILINOIMIDAZOPYRIDINES AND METHODS FOR USING THEM | 2008 |
|
RU2441004C1 |
AZABENZOFURANYL COMPOUNDS AND METHODS OF USE | 2007 |
|
RU2448111C2 |
AZAINDOLIZINES AND METHODS FOR PREPARING THEM | 2008 |
|
RU2483069C2 |
DIAZACARBAZOLES AND METHODS OF APPLICATION | 2009 |
|
RU2515972C2 |
TRIAZINE, PYRIMIDINE AND PYRIDINE ANALOGUES AND USE THEREOF AS THERAPEUTIC AGENTS AND DIAGNOSTIC SAMPLES | 2009 |
|
RU2537945C2 |
ANNEALED (OXA)-HYDANTOINS, METHODS FOR THEIR PRODUCTION, HERBICIDE COMPOSITION AND METHOD FOR CONTROL OF WEEDS | 1993 |
|
RU2113439C1 |
Authors
Dates
2013-10-10—Published
2009-07-01—Filed